N
Centralnervesystemet
Parkinsons sygdom
Antiparkinsonmidler
Levodopa kombineret med decarboxylasehæmmer
MAO-B-hæmmere
COMT-hæmmere
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
Dopaminagonister
Antikolinerge midler
Amantadin
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
N04BA
Revideret: 20.10.2021
Karen Østergaard (Forfatter),
Dansk Neurologisk Selskab
Tove Henriksen (Referent),
Dansk Selskab for Bevægeforstyrrelser
Indledning | Anvendelsesområder | Behandlingsvejledning | Præparatvalg | Doseringsforslag | Nedsat lever- og/eller nyrefunktion | Kontraindikationer | Forsigtighedsregler | Patientsikkerhed | Bivirkninger | Interaktioner | Graviditet | Amning | Forgiftning | Farmakodynamik | Farmakokinetik | Tilskud | Præparater | Referencer
Der henvises i øvrigt også til Levodopa kombineret med decarboxylasehæmmer og COMT-hæmmere for en oversigt over præparater med indholdsstofferne hver for sig.
For yderligere oplysninger om behandling af Parkinsons sygdom, se antiparkinsonmidler.
Præparater
| Indholdsstof | Navn og firma | Dispform og styrke | Pakning | Pris enh. | Pris DDD |
|---|---|---|---|---|---|
| Carbidopa Entacapon Levodopa |
Garir Parallelimport
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | 10,85 | 24,40 |
| Carbidopa Entacapon Levodopa |
Lecigon® Nordic Infucare
|
enteralgel 20+5+20 mg/ml | 7 x 47 ml | 24,26 | 545,94 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 100 stk. | 1,70 | 15,33 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 130 stk. | 3,43 | 30,83 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. | 4,39 | 26,32 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 130 stk. | 9,36 | 56,17 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 3,82 | 17,19 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 6,22 | 28,01 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk | 5,22 | 18,80 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 130 stk. | 9,73 | 35,03 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk | 9,51 | 28,54 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 4,11 | 12,33 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | 11,01 | 24,79 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 130 stk. | 12,14 | 27,33 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 175+43,75+200 mg | 100 stk | 4,71 | 12,10 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Teva" SanoSwiss
Udgået
16.10.2023
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk. | ||
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 3,80 | 17,10 |
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | ||
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 30 stk. | 13,42 | 60,39 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 13,14 | 59,13 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 10,76 | 48,41 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. | 13,14 | 39,42 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 10,76 | 32,27 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 30 stk. | 13,53 | 30,45 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | 12,04 | 27,08 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. (Medartuum) | 10,67 | 24,02 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. (2care4) | 10,86 | 24,44 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. (2care4) | 4,39 | 26,36 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 130 stk. | 9,60 | 57,59 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk.( 2care4) | 5,21 | 18,77 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 130 stk. | 9,89 | 35,59 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 175+43,75+200 mg | 130 stk. | 7,75 | 19,93 |
Referencer
1563. Stocchi F, Rascol O, Kieburtz K et al. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010; 68(1):18-27, https://pubmed.ncbi.nlm.nih.gov/20582993/ (Lokaliseret 10. december 2021)
4678. Stoessl AJ. Continuous dopaminergic therapy in Parkinson disease: time to stride back?. Ann Neurol. 2010; 68:3-5, https://www.ncbi.nlm.nih.gov/pubmed/20583222 (Lokaliseret 17. oktober 2023)
